News

Old Second Bancorp's Target Boosted to $18 Amid Strong Earnings

Old Second Bancorp's Target Boosted to $18 Amid Strong Earnings

Old Second Bancorp Sees Price Target Increase

Recently, Old Second Bancorp (NASDAQ: OSBC) experienced a raise in its price target from $16.00 to $18.00, as announced by DA Davidson. While the firm maintained a Neutral rating on the stock, this adjustment reflects a more optimistic perspective on the bank's net interest income (NII) and credit quality.

Positive Trends in Credit Metrics

DA Davidson's analysis highlighted a notable improvement in the bank's credit metrics. Specifically, there was a decrease in classified assets and a reduction in charge-offs during the third quarter of 2024. However, not all was rosy, as the firm noted that non-performing asset (NPA) levels have begun to rise again.

Net Interest Income Surpasses Expectations

The performance metrics concerning net interest income and net interest margin (NIM) were reported to significantly exceed expectations. This positive performance prompted DA Davidson to reevaluate its guidance on potential negative impacts stemming from interest rate cuts, suggesting that their prior outlook may have been overly conservative.

Growth in Earnings Per Share Forecast

Reflecting these positive trends, DA Davidson raised its earnings per share (EPS) forecast for Old Second Bancorp. The firm attributed the increase in the price target primarily to a better-than-expected NII forecast, which ultimately shaped their decision to maintain a Neutral stance on the stock.

Comments from DA Davidson

An analyst from DA Davidson remarked, "With classified assets and charge-offs down, the main credit message was positive in 3Q24 despite an uptick in NPA levels. Further credit workout remains under review in our estimation. On the NII/NIM front, the bank has clearly outperformed expectations, suggesting that prior guidance on the negative impact of rate cuts on NIM was indeed conservative. This led us to increase our EPS outlook, reflecting our latest insights on NII and adjusting our price target accordingly, while still maintaining our Neutral rating."">

Quarterly Performance Highlights

In addition to the analysts' insights, Old Second Bancorp's reported Q3 2024 earnings showcased an operating EPS of $0.52, outpacing both consensus and Piper Sandler's expectations. Influencing this reported EPS were factors like a negative mortgage servicing rights fair value adjustment and costs related to branch acquisitions. Piper Sandler attributed this strong performance to enhanced NII, core fee income, a lower loan loss provision, and an advantageous tax rate.

Robust Returns and Dividend Announcement

The company demonstrated solid revenue generation and impressive profitability, marked by a return on assets (ROA) of 1.6% and a return on tangible common equity (ROTCE) of 17.1% during the third quarter. Additionally, the company declared a quarterly cash dividend of $0.06 per share, reinforcing its commitment to returning value to shareholders.

Analyst Ratings and Future Outlook

Despite the positive news regarding its price target increase, analysts at DA Davidson recently downgraded Old Second Bancorp from a Buy to Neutral. This decision stemmed from concerns about the bank's less favorable asset-sensitive balance sheet position and rising pressure on the net interest margin.

Overview of Recent Financial Developments

In further financial updates, Old Second Bancorp reported its Q2 2024 results, indicating a net income of $21.9 million or $0.48 per diluted share, with loan growth in commercial, lease, and construction portfolios totaling $7.2 million. The bank is also evaluating potential mergers and acquisitions, seeking disciplined pricing in any future activities.

Insights from Additional Analysis

Recent data from alternative analysis sources provides additional context on Old Second Bancorp's (OSBC) financial performance. The company has shown consistent profitability over the previous twelve months, aligning with analysts’ anticipations for ongoing profitability this year. This observation supports the positive stance from DA Davidson regarding the bank's NII.

Dividend History and Market Performance

Moreover, OSBC has maintained dividend payments for nine straight years, indicating a strong commitment to returning value to shareholders. Currently, the stock is trading near its 52-week high, which could signal market confidence in the bank's recent achievements and future potential.

Frequently Asked Questions

What is Old Second Bancorp's current price target?

Old Second Bancorp's price target has been raised to $18.00.

Who is responsible for the recent price target increase?

The increase was made by DA Davidson, which maintains a Neutral rating on the stock.

What recent financial performance metrics were reported?

The bank reported an operating EPS of $0.52 for Q3 2024, surpassing consensus estimates.

Why was Old Second Bancorp downgraded?

DA Davidson downgraded the bank from Buy to Neutral due to concerns over its asset-sensitive balance sheet and increased NIM pressure.

How long has Old Second Bancorp maintained dividends?

Old Second Bancorp has consistently paid dividends for nine years, showcasing its commitment to shareholders.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Nocpix's Evolution: New Thermal Riflescope Unveiled

Updated Category News Views 2

Raising the Thermal Image Bar When Nocpix, known for cutting-edge electro-optical tech, teases a new thermal riflescope, it's time for hunters to perk up. This ain't just another gadget. We're talking about equipment that elevates precision and brings an edge to the field. Scheduled for hunters who mean business, this next-gen scope is destined to redefine what it means...

Continue Reading
Dreame Unveils Vast AI Product Range at IFA 2026

Updated Category News Views 3

Overnight Sensation or Future Staple? I wonder if Dreame's top brass woke up sweating or smiling after their big reveal at IFA 2026. A buffet of over 100 products across 16 categories is no small feat, especially when you're banking on technologies developed over nine years. But let's cut through the noise—does this showcase promise innovation or just smoke and mirrors?...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 2

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
viaim's AI Earbuds Snag IFA Awards, Launch On Indiegogo

Updated Category News Views 1

When the tech cosmos hands you two hefty IFA Innovation Awards, you know you’re onto something. viaim’s Rise wasn't just about slick marketing—it brought home the 'Best in Audio' and 'Best in Design' titles from IFA 2026, proving these earbuds are more than just another gadget. Key Innovations Behind the Accolades IFA is no small affair—it's a major tech trade...

Continue Reading
Why Buyers Are Flocking to Whidbey Island Homes

Updated Category News Views 1

Something's got folks eyeing Whidbey Island like a gambler with a hot tip—and it ain't just the thrill of a vacation spot. Anyone with half a brain knows real estate moves in waves, and right now, Whidbey Island's caught some serious momentum. You can't ignore the pull of natural beauty, access to city life, and that laid-back vibe that seems to whisper "slow down and...

Continue Reading
Evolve & ELITEWHEELS: Shifting Gears in European Cycling

Updated Category News Views 3

Revving Up for the European Cycling Scene There's something about the open road and the whirr of wheels that gets blood pumping—maybe it's the competition, maybe it's the gear. Either way, this year's Italian Bike Festival is turning the Misano World Circuit into a battleground for cycling's elite, with evolve and ELITEWHEELS charging at the forefront. They're not just...

Continue Reading
Hisense Showcases AI in Everyday Living at IFA 2026

Updated Category News Views 5

Hisense's Vision: An AI Utopia for Home Take this in: Hisense is cooking something bold at IFA 2026. They're pushing the envelope by integrating AI into our daily grind, promising to change the way we interact with the spaces that matter most. No more just dreaming about futuristic homes—these guys seem dead set on making them our everyday reality. Connected...

Continue Reading
Midea's SpaceMaster Oven: Revolutionizing Home Pizza

Updated Category News Views 1

Oven Culture: Beyond Simple Baking When it comes to the kitchen, we're always promised more than we get. You know the spiel: the heart of the home, a place for traditions. But honestly? Most ovens are about as exciting as watching paint dry. Often too cramped, uneven, and a pain in the backside to preheat. But then, out of the burning blue, Midea comes along with their...

Continue Reading
Testing Grounds: Navigating PRN Test Insights

Updated Category News Views 1

Deciphering the PRN Tester Repetition Today we're staring at what feels like déjà vu—a simple PR test peppered with the classic sentence about a fox and a dog. It's like someone left the 'repeat' function stuck on during a slow day at the office. But hey, let’s dig in. Is there something more behind this repetitive text, or are we grumbling at a wall? Unpacking the...

Continue Reading
Auto Maintenance: Key Tips for Long-Term Vehicle Health

Updated Category News Views 3

Beating Breakdown Blues: Preventative Maintenance Insights You ever look under the hood and wonder what's ticking away? Cars ain't just about turning keys and hitting gas—there's a beating heart under all that metal and rubber. That's what HelloNation's serving us here, with David Mantz and his kid, David Mantz Jr., lifting the lid on preventative maintenance. These...

Continue Reading

Top 5 Most Recently Viewed Articles

Talisker Resources Successfully Closes Gold-Linked Note Deal

Updated Category News Views 49

Talisker Resources Announces Successful Financing Initiative Talisker Resources Ltd. (TSK) has made headlines with the completion of its latest financing venture involving $1.33 million through the issuance of gold-linked notes. This strategic move is set to propel the progress of Talisker's flagship project, the Bralorne Gold Project, which is currently undergoing...

Continue Reading
FDA Approves Novartis' Kisqali, Expanding Breast Cancer Treatment

Updated Category News Views 133

FDA Approves Novartis' Kisqali: A Major Step Forward in Breast Cancer Care Novartis (NYSE: NVS) has reached a crucial milestone with the FDA's approval of Kisqali (ribociclib), now available for a broader group of patients facing early-stage breast cancer. This approval represents a significant leap in treating hormone receptor-positive/human epidermal growth factor...

Continue Reading
Mounting Challenges for Mobileye N.V: Insights into Stock Outlook

Updated Category News Views 101

Mobileye Faces Downgrade as Transition Year Approaches Recently, UBS has revised its outlook on Mobileye N.V (NASDAQ:MBLY), a leader in autonomous driving technologies. The firm has downgraded the stock from Buy to Neutral, with a lowered price target of $14.00, decreasing from an earlier target of $20.00. This decision is primarily due to the company's current struggles,...

Continue Reading
Plans for Spending Cuts and Subsidy Eliminations Revealed

Updated Category News Views 118

Plans for Federal Spending Cuts and Subsidy Eliminations John Paulson, a billionaire investor known for his connections with former President Donald Trump, has outlined his strategy for significant federal spending reductions if he were to be appointed as Treasury Secretary. Collaborating with Elon Musk, Paulson seeks to minimize government expenditures, particularly by...

Continue Reading
Brazil’s Finance Minister Prepares for Key Fiscal Announcements

Updated Category News Views 35

Brazil's Finance Minister Prepares for Key Fiscal Announcements Brazil's Finance Minister Fernando Haddad has recently indicated that significant fiscal measures aimed at supporting the country’s financial framework might be unveiled shortly. This announcement comes as the government approaches the final stages of preparation for what could be a pivotal moment in...

Continue Reading